[CAS NO. 2248003-60-1] AZD3229
PRODUCTS SPECIFICATIONS [2248003-60-1]
DESCRIPTION [2248003-60-1]
Overview
| MDL | - |
|---|---|
| Molecular Weight | 479.51 |
| Molecular Formula | C24H26FN7O3 |
| SMILES | COCCOC1=CC(F)=C2C(N=CN=C2NC3=CC=C(NC(CN4C=C(C(C)C)N=N4)=O)C=C3)=C1 |
Summary
AZD3229 is a potent pan- KIT mutant inhibitor for the treatment of gastrointestinal stromal tumors.
IC50 & Target
KIT [1] .
In Vitro
AZD3229 is a potent, pan-KIT mutant inhibitor with potent single digit nM growth inhibition against a diverse panel of mutant KIT driven Ba/F3 cell lines (GI 50 =1-50 nM). AZD3229 demonstrates potent single digit nM growth inhibition across a broad cell panel, with good margin to KDR-driven effects. Selectivity over KDR can be rationalised predominantly by the interaction of water molecules with the protein and ligand in the active site and its kinome selectivity is similar to the best of the approved GIST agents [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
DMSO : 40 mg/mL ( 83.42 mM ; Need ultrasonic)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.0855 mL | 10.4273 mL | 20.8546 mL |
| 5 mM | 0.4171 mL | 2.0855 mL | 4.1709 mL |
| 10 mM | 0.2085 mL | 1.0427 mL | 2.0855 mL |